Trials / Terminated
TerminatedNCT02903082
Following of Myeloid-derived Suppressor Cells (MDSC) in Severe Sepsis: What Relationship With Systemic Inflammatory Syndrome?
- Status
- Terminated
- Phase
- —
- Study type
- Observational
- Enrollment
- 68 (actual)
- Sponsor
- University Hospital, Limoges · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
Sepsis remains a major cause of death in developed countries. A better understanding of the mechanisms involved in the regulation of inflammatory and immune response of patients with severe sepsis is an important step that could open the way for new therapeutic approaches.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| BIOLOGICAL | Residue of blood further to NFS | |
| BIOLOGICAL | Residue of blood further to preoperative workup | |
| BIOLOGICAL | Bone marrow collected during a myelogram carried out for hematological pathology workup | |
| BIOLOGICAL | Bone marrow collected during myelogram routinely performed during hospitalization in ICU |
Timeline
- Start date
- 2015-04-01
- Primary completion
- 2018-01-01
- Completion
- 2018-01-01
- First posted
- 2016-09-16
- Last updated
- 2019-01-28
Locations
1 site across 1 country: France
Source: ClinicalTrials.gov record NCT02903082. Inclusion in this directory is not an endorsement.